您要查找的是不是：
- Objective To evaluate the treatment of portal hypertensi on caused by tumor thrombi with percutaneous transhepatic portal vein stent implan tation under the US guidance. 目的探讨通过超声引导经皮肝穿途径向门脉内放置内支架治疗癌栓引起的门静脉高压的效果。
- transhepatic portal vein catheterization 经肝门静脉插管(术)
- transhepatic portal vein 经肝门静脉
- Strategy of Therapy for Portal Vein Spongiform in Children. 小儿门静脉海绵样变治疗的思路。
- There were no tumor thrombi in the main portal vein. 门静脉主干内未及癌栓。
- Of or relating to the portal vein or the portal system. 门静脉门静脉的，门静脉系统的，与门静脉系统有关的
- The color flow of the portal vein revealed no color,red,mosaic or filling defect. 结果 :pv内CDFI可显示本色、红色、混色或充盈缺损。
- MRI also suggested hepatic metastasis in 4 cases, portal vein invasion in 7 cases. MRI发现 4例肝转移 ,7例门静脉主干或分支受累。
- TPC(transhepatic portal catheterization) 经肝门静脉插管术
- transhepatic portal catheterization 经肝门静脉插管术
- Results The main portal vein appearance was accordant with 3D CE MRP and direct x-ray portography in all cases. 结果3D CE mrp和直接门静脉造影显示门静脉主干的结果完全一致。
- transhepatic portal venous sampling 经肝门静脉取样
- percutaneous transhepatic portal phlebography 经皮经肝门静脉造影(术)
- Preliminary survival observation on purcutaneous portal vein chronomodulated chemotherapy on treatment of liver cancer. 肝癌经皮门静脉时辰化疗生存期的初步观察。
- Samples of blood were collected from the radial artery, portal vein (PV) and hepatic vein (HV), in up to 120 minutes postreperfusion. 再灌注后120分钟后从桡动脉、门静脉和肝静脉采血液样本。
- The portal vein injection of LUF in the rats is simple procedure and the results are reliable. 活体碘油门静脉灌注方法简单易行,结果真实可靠;
- Compared with 30% PH,70% PH could obviously increase hepatocyte transgenic efficiency via rat portal vein. 与 30%25肝部分切除术相比 ,70%25切肝可显著提高大鼠肝细胞门静脉途径转基因的效率
- DST,DSSL and DSBM can induce the specific tolerance by the way of portal vein infusion. 发现供者特异性输血（DST）、供者特异性脾细胞（DSSL）和供者特异性骨髓细胞（DSBM）能诱导受体对供体移植物产生免疫耐受。
- Methods 108 3D DCE MRA and 10 2D DCE MRA were performed and compared in visulization of the right Portal vein branches. 方法门静脉和肝脏静脉系统行3DDCEMRA108次，二维（2D）DCEMRA10次。
- Index of bore of portal vein was lower in treatment group than that in control group after treatment (P < 0.01). 治疗组治疗后门静脉内径明显小于对照组(P<0.;05)。
